Comparison of primary percutaneous coronary intervention and fibrinolytic therapy in st-segmentelevation myocardial infarction: Bayesian hierarchical meta-analyses of randomized controlled trials and observational studies

Circulation

Volumn 119, Issue 24, 2009, Pages 3101-3109

  Huynh, Thao ^a,g   Perron, Stephane ^c   O'Loughlin, Jennifer ^c   Joseph, Lawrence ^b   Labrecque, Michel ^e   Tu, Jack V ^f   Théroux, Pierre ^d  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d MONTREAL HEART INSTITUTE   (Canada)

^e UNIVERSITÉ LAVAL   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g NONE   (Canada)

Author keywords

Angioplasty; Coronary disease; Fibrinolysis; Myocardial infarction; Percutaneous coronary intervention; Thrombolysis

Indexed keywords

FIBRINOLYTIC AGENT;

ARTICLE; BAYES THEOREM; CLINICAL TRIAL; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART INFARCTION; HEART REINFARCTION; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK REDUCTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STROKE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 67649516626     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.793745     Document Type: Article

References (68)

1. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, Abildgaard U, Pedersen F, Madsen JK, Grande P, Villadsen AB, Krusell LR, Haghfelt T, Lomholt P, Husted SE, Vigholt E, Kjaergard HK, Mortensen LS. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 2003; 349:733-742.
2. Armstrong PW, for the WEST Steering Committee. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-Elevation Myocardial Infarction Therapy) study. Eur Heart J. 2006;27:1530-1538.
3. Aversano T, Aversano LT, Passamani E, Knatterud GK, Terrin, MT, Williams DO, Forman SA, for the Atlantic Cardiovascular Patient Outcomes Research Team. Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial. JAMA. 2002;287:1943-1951.
4. Bonnefoy E, Lapostolle F, Leizorovicz A, Steg G, McFadden EP, Dubien PY, Cattan S, Boullenger E, Machecourt J, Lacroute JM, Cassagnes J, Dissait F, Touboul P, for the Comparison of Angioplasty and Prehospital Thrombolysis in Acute Myocardial Infarction (CAPTIM) Study Group. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet. 2002;360:825-829.
5. De Boer MJ, Ottervanger JP, van't Hof AWJ, Hoorntje JCA, Suryapranata H, Zijlstra F, for the Zwolle Myocardial Infarction Study Group. Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy. J Am Coll Cardiol. 2002;39:1723-1728.
6. Garcia E, Elizaga J, Perez-Castellano N, Serrano JA, Soriano J, Abeytua M, Botas J, Rubio R, Lopez de Sa E, Lopez-Sendon JL, Delcan JL. Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction. J Am Coll Cardiol. 1999;33:605-611.
7. Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopfenspirger MR, Gersh BJ, for the Mayo Coronary Care Unit and Catheterization Laboratory groups. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med. 1993;328:685-691.
8. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J, Overlie P, Donohue B, Chelliah N, Timmis GC, Vlietstra RE, Strzelecki M, Puchrowicz-Ochocki S, O'Neill WW, for the Primary Angioplasty in Myocardial Infarction Study Group. A comparison of immediate angio-plasty with thrombolytic therapy for acute myocardial infarction: the Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med. 1993;328:673-679.
9. Grines CL, Westerhausen DR Jr, Grines LL, Hanlon T, Logemann TL, Niemela M, Weaver WD, Graham M, Boura J, O'Neill WW, Balestrini C, for the Air-PAMI Study Group. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myo-cardial infarction: the Air Primary Angioplasty in Myocardial Infarction Study. J Am Coll Cardiol. 2002;39:1713-1719.
10. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction: Angioplasty Substudy Investigators. N Engl J Med. 1997;336:1621-1628.
11. Kastrati A, Mehilli J, Dirschinger J, Schricke U, Neverve J, Pache J, Martinoff S, Neumann FJ, Nekolla S, Blasini R, Seyfarth M, Schwaiger M, Schömig A, for the Stent Versus Thrombolysis for Occluded Coronary Arteries in Patients With Acute Myocardial Infarction (STOPAMI-2) Study. Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial. Lancet. 2002;359:920-925.
12. Le May MR, Labinaz M, Davies RF, Marquis JF, Laramee LA, O'Brien ER, Williams WL, Beanlands RS, Nichol G, Higginson LA. Stenting versus thrombolysis in acute myocardial infarction trial (STAT). J Am Coll Cardiol. 2001;37:985-991.
13. Ribeiro EE, Silva LA, Carneiro R, D'Oliveira LG, Gasquez A, Amino JG, Tavares JR, Petrizzo A, Torossian S, Duprat Filho R. Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction. J Am Coll Cardiol. 1993;22:376-380.
14. Ribichini F, Steffenino G, Dellavalle A, Ferrero V, Vado A, Feola M, Uslenghi E. Comparison of thrombolytic therapy and primary coronary angioplasty with liberal stenting for inferior myocardial infarction with precordial ST-segment depression: immediate and long-term results of a randomized study. J Am Coll Cardiol. 1998;32:1687-1694.
15. Schomig A, Kastrati A, Dirschinger J, Mehilli J, Schricke U, Pache J, Martinof S, Neumann FJ, Schwaiger M, for the Stent Versus Thrombol-ysis for Occluded Coronary Arteries in Patients With Acute Myocardial Infarction Study Investigators. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. N Engl J Med. 2000;343:385-391.
16. Widimsky P, Groch L, Zelizko M, Aschermann M, Bednar F, Suryapranata H, for the PRAGUE Study Group Investigators. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory: the PRAGUE study. Eur Heart J. 2000;21:823-831.
17. Widimsky P, Budesinsky T, Vorac D, Groch L, Zelízko M, Aschermann M, Branny M, St'ásek J, Formánek P, for the PRAGUE Study Group Investigators. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction: final results of the randomized national multicentre trial-PRAGUE-2. Eur Heart J. 2003; 24:94-104.
18. Berrocal DH, Cohen MG, Spinetta AD, Ben MG, Rojas Matas R, Gabay JM, Magni JM, Nogareda G, Oberti P, Von Schulz C, Doval H, Bazzino OO, Cagide A, Oliveri R, Grinfeld LR. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase. Am Heart J. 2003;146:e22.
19. Svensson L, Aasa M, Dellborg M, Gibson CM, Kirtane A, Herlitz J, Ohlsson A, Karlsson T, Grip L. Comparison of very early treatment with either fibrinolysis or percutaneous coronary intervention facilitated with abciximab with respect to ST recovery and infarct-related artery epicardial flow in patients with acute ST-segment elevation myocardial infarction: the Swedish Early Decision (SWEDES) reperfusion trial. Am Heart J. 2006;151:798 e1-e7.
20. Dieker HJ, van Horssen EV, Hersbach FM, Brouwer MA, van Boven AJ, van't Hof AW, Aengevaeren WR, Verheught FW, Bar FW. Transport for abciximab facilitated primary angioplasty versus on-site thrombolysis with a liberal rescue policy: the randomised Holland Infarction Study (HIS). J Thromb Thrombolysis. 2006;22:39-45.
21. Dobrzycki S, Kralisz P, Nowak K, Prokopczuk P, Kochman W, Korecki J, Poniatowski B, Zuk J, Sitniewska E, Bachorzewska-Gajewska H, Sienkiewicz J, Musial WJ. Transfer with GPIIb/IIIa inhibitor tirofiban for primary percutaneous coronary intervention vs on-site thrombolysis in patients with ST-elevation myocardial infarction: a randomized open-label study for patients admitted to community hospitals. Eur Heart J. 2007;28:2438-2448.
22. Vermeer F, Oude Ophuis AJ, vd Berg EJ, Brunninkhuis LG, Werter CJ, Boehmer AG, Lousberg AH, Dassen WR, Bar FW. Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study. Heart. 1999;82:426-431.
23. Zijlstra F, Hoorntje JCA, de Boer MK, Reiffers S, Miedema K, Ottervanger JP, van't Hof AWJ, and Suryapranata H. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 1999;341:1413-1419.
24. Every NR, Parsons LS, Hlatky M, Martin JS, Weaver WD. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction: Myocardial Infarction Triage and Intervention Investigators. N Engl J Med. 1996;335:1253-1260.
25. Gurwitz JH, Col NF, Avorn J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA. 1992;268:1417-1422.
26. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342:1887-1892.
27. Lauer MS, Topol EJ. Clinical trials: multiple treatments, multiple end-points and multiple lessons. JAMA. 2003;289:2575-2577.
28. Altman DG, Schulz KF, Moher D, Egger M, Davidoff, Elbourne D, Gotzsche PC, Lang T, for the CONSORT Group. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134:663-694.
29. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting meta-analysis of observational studies in epidemiology. JAMA. 2000;283:2008-2012.
30. Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA. 1999;282:1054 -1060.
31. Warn DE, Thompson SG, Spiegelhalter DJ. Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales. Stat Med. 2002;21:1601-1623.
32. Zeymer U, Gitt AK, Junger C, Heer T, Heer T, Wienbergen H, Koeth O, Bauer T, Mark B, Zahn R, Gottwik M, Senges J, for the Acute Coronary Syndromes (ACOS) Registry Investigators. Effect of clopidogrel on 1-year mortality in hospital survivors of acute ST-segment elevation myocardial infarction in clinical practice. Eur Heart J. 2006;27:2661-2666.
33. Rogers WJ, Dean LS, Moore PB, Wool KJ, Burgard SL, Bradley EL. Comparison of primary angioplasty versus thrombolytic therapy for acute myocardial infarction: Alabama Registry of Myocardial Ischemia Investigators. Am J Cardiol. 1994;74:111-118.
34. Steffenino G, Santoro GM, Maras P, Mauri F, Ardissino D, Violini R, Chiarella F, Lucci D, Marini M, Baldasseroni S, Maggionni AP. In-hospital and one-year outcomes of patients with high-risk acute myocardial infarction treated with thrombolysis or primary coronary angioplasty. Ital Heart J. 2004;5:136-145.
35. Stenestrand U, Lindback J, Wallentin L, for the RIKS-HIA Registry. Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction. JAMA. 2006;296:1749-1756.
36. Bardaji A, Bueno H, Fernandez-Ortiz A, Cequier A, Auge JM, Heras M. Type of treatment and short-term outcome in elderly patients with acute myocardial infarction admitted to hospitals with a primary coronary angioplasty facility: the TRIANA (Tratamiento del Infarto Agudo de Miocardio en Ancianos) Registry. Rev Esp Cardiol. 2005;58:351-358.
37. Bueno H, Martinez-Selles M, Perez-David E, López-Palop R. Effect of thrombolytic therapy on the risk of cardiac rupture and mortality in older patients with first acute myocardial infarction. Eur Heart J. 2005;26:1705-1711.
38. Danchin N, Vaur L, Genès N, Etienne S, Angioï M, Ferrières J, Cambou JP. Treatment of acute myocardial infarction by primary coronary angio-plasty or intravenous thrombolysis in the "real world": one-year results from a nationwide French survey. Circulation. 1999;99:2639-2644.
39. Danchin N, Blanchard D, Steg, PG, Sauval P, Hanania G, Goldstein P, Cambou JP, Gueret P, Vaur L, Boutalbi Y, Genès N, Lablanche JM, for the USIC 2000 Investigators. Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry. Circ. 2004;110:1909-1915.
40. Fassa AA, Urban P, Radovanovic D, Duvoisin N, Gaspoz JM, Stauffer JC, Erne P. Temporal trends in treatment of ST segment elevation myo-cardial infarction in Switzerland from 1997 to 2005. Rev Med Suisse. 2006;2:1393-1396.
41. Goldenberg I, Matetzky S, Halkin A, Roth A, Di Segni E, Freimark D, Elian D, Agranat O, Har Zahav Y, Guetta V, Hod H. Primary angioplasty with routine stenting compared with thrombolytic therapy in elderly patients with acute myocardial infarction. Am Heart J. 2003;145:862-867.
42. Hsu LF, Mak KH, Lau KW, Sim LL, Chan C, Koh TH, Chuah SC, Kam R, Ding ZP, Teo WS, Lim YL. Clinical outcomes of patients with diabetes mellitus and acute myocardial infarction treated with primary angioplasty or fibrinolysis. Heart. 2002;88:260 -265.
43. Kalla K, Christ G, Karnik R, Malzer R, Norman G, Prachar H, Schreiber W, Unger G, Glogar HD, Kaff A, Laggner AN, Maurer G, Mlczoch J, Slany J, Weber HS, Huber K, for the Vienna STEMI Registry Group. Implementation of guidelines improves the standard of care: the Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI registry). Circulation. 2006;113:2398-2405.
44. Mehta RH, Sadiq I, Goldberg RJ, Gore JM, Avezum A, Spencer F, Kline-Rogers E, Allegrone J, Pieper K, Fox KA, Eagle KA, for the GRACE Investigators. Effectiveness of primary percutaneous coronary intervention compared with that of thrombolytic therapy in elderly patients with acute myocardial infarction. Am Heart J. 2004;147:253-259.
45. Ober MC, Ober C, Hagau A, Mot S, Iancu A, Literat S, Capalineanu R. Prodromal angina reduces infarcted mass less in interventionally reperfused than in thrombolysed myocardial infarction. Rom J Intern Med. 2004;42:533-543.
46. Sakurai K, Watanabe J, Iwabuchi K, Koseiki Y, Kon-no Y, Fukuchi M, Komaru T, Shinozaki T, Miura M, Sakuma M, Kagaya Y, Kitaoka S, Shirato K. Comparison of the efficacy of reperfusion therapies for early mortality from acute myocardial infarction in Japan: registry of Miyagi Study Group for AMI (MsAMI). Circ J. 2003;67:209-214.
47. Solodky A, Assali AR, Behar S, Boyko V, Battler A, Kornowski R. Anterior wall myocardial infarction in real world: does reperfusion strategy make any differences? Catheter Cardiovasc Interv. 2004;61:79 - 83.
48. Huynh T, O'Loughlin J, Joseph L, Schampaert E, Rinfret S, Afilalo M, Kouz S, Cantin B, Nguyen M, Eisenberg MJ, for the AMI-QUEBEC Study Investigators. Delays to reperfusion therapy in acute ST-segment elevation myocardial infarction: results from the AMI-QUEBEC Study. Can Med Assoc J. 2006;175:1527-1532.
49. Chanut C, Boyer L, Robitail S, Barrau K, Grellier J, Allegrini S, Horte C, Mabriez JC. Retrospective survey of the management of patients treated for acute myocardial infarction in Provence-Alpes-Cote d'Azur. Ann Cardiol Angeiol. 2005;54:60-67.
50. de Labriolle A, Pacouret G, Bertrand P, de Labriolle A, Pacouret G, Bertrand P, Barbey C, Magdelaine B, Desveaux B, Quilliet L, Fauchier L, Charbonnier B. Effects of delay in onset of revascularisation strategies in the acute phase of myocardial infarction. Arch Mal Coeur Vaiss. 2006; 99:7-12.
51. Dryja T, Kornacewicz-Jach Z, Goracy J, Przybycień K, Jodko L, Skowronek A, Kurowski M, Zinka E. Treatment of acute ST-segment elevation myocardial infarction in West Pomerania province of Poland: comparison between primary coronary intervention and thrombolytic therapy. Kardiol Pol. 2006;64:591-599.
52. Brush JE Jr, Thompson S, Ciuffo AA, Parker J, Stine RA, Mansfield CL, Hagerman P. Retrospective comparison of a strategy of primary coronary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction in a community hospital without cardiac surgical backup. J Invasive Cardiol. 1996;8:91-98.
53. Hansen HH, Thuesen L, Rasmussen K, Andersen HR, Vesterlund T, Villadsen AB, Schroeder AP, Husted SE, Nielsen TT. Percutaneous transluminal coronary angioplasty versus thrombolysis in acute myocardial infarction. Scand Cardiovasc J. 2000;34:365-370.
54. Berger AK, Radford MJ, Wang Y, Krumholz HM. Thrombolytic therapy in older patients. J Am Coll Cardiol. 2000;36:366-374.
55. Zahn R, Schiele R, Schneider S, Gitt AK, Wienbergen H, Seidl K, Voigtlander T, Gottwik M, Berg G, Altmann E, Rosahl W, Senges J, for the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) and the Myocardial Infarction Registry (MIR) study groups. Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty. J Am Coll Cardiol. 2001;37:1827-1835.
56. Magid DJ, Wang Y, Herrin J, McNamara RL, Bradley EH, Curtis JP, Pollack CV Jr, French WJ, Blaney ME, Krumholz HM. Relationship between time of day, day of week, timeliness of reperfusion, and in-hospital mortality for patients with acute ST-segment elevation myocardial infarction. JAMA. 2005;294:803-812.
57. Ferrier C, Belle L, Labarere J, Fourny M, Vanzetto G, Guenot O, Debaty G, Savary D, Machecourt J, François P. Comparison of mortality according to the revascularisation strategies and the symptom-to-management delay in ST-segment elevation myocardial infarction. Arch Mal Coeur Vaiss. 2007;100:13-19.
58. Tungsubutra W, Tresukosol D, Krittayaphong R, Panchavinnin P, Phankingtongkhum R, Chotnaiwattarakul C. Primary percutaneous transluminal coronary intervention compared with intravenous thrombolysis in patients with ST-segment elevation myocardial infarction. J Med Assoc Thai. 2007;90:672-678.
59. Martinez-Selles M, Datino T, Bueno H. Influence of reperfusion therapy on prognosis in patients aged >89 years with acute myocardial infarction. Am J Cardiol. 2005;1232-1234.
60. Di Pede F, Olivari Z, Schievano E, Spolaore P, Cacciavillani L, La Vecchia L, Bruni A, Zuin G, Franco GF, Palatini O, Morando G, Tinto M, Rossi M, Guarnerio M, for the Ricercatori del Registro VENERE. Impact of reperfusion strategies on in-hospital outcome in ST-elevation myocardial infarction in a context of interhospital network: data from the prospective VENERE registry. Ital Heart J Suppl. 2005;6:804-811.
61. Zeymer U, Schroder R, Machnig T, Neuhaus KL. Primary percutaneous transluminal coronary angioplasty accelerates early myocardial reperfusion compared to thrombolytic therapy in patients with acute myocardial infarction. Am Heart J. 2003;146:686-691.
62. Roncalli J, Brunelle F, Galinier M, Carrié D, Fourcade J, Elbaz M, Gaston JP, Charpentier S, Puel J, Fauvel JM. Pre-hospital fibrinolysis followed by angioplasty or primary angioplasty in acute myocardial infarction: the long-term clinical outcome. J Thromb Thrombolysis. 2003;15:181-188.
63. Bednar F, Widimsky P, Krupicka J, Bednár F, Widimský P, Krupicka J, Groch L, Aschermann M, Zelízko M, for the PRAGUE Study Group Investigators. Interhospital transport for primary angioplasty improves the long-term outcome of acute myocardial infarction compared with immediate thrombolysis in the nearest hospital (one-year follow-up of the PRAGUE-1 Study). Can J Cardiol. 2003;19:1133-1137.
64. Nunn CM, O'Neill WW, Rothbaum D, Stone GW, O'Keefe J, Overlie P, Donohue B, Grines L, Browne KF, Vlietstra RE, Catlin T, Grines CL. Long-term outcome after primary angioplasty: report from the Primary Angioplasty in Myocardial Infarction (PAMI-I) trial. J Am Coll Cardiol. 1999;33:640-646.
65. Busk M, Maeng M, Rasmussen K, Kelbaek H, Thayssen P, Abildgaard U, Vigholt E, Mortensen LS, Thuesen L, Kristensen SD, Nielsen TT, Andersen HR, for the DANAMI-2 Investigators. The Danish Randomized Multicenter Study of Fibrinolytic Therapy vs Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction (the DANAMI-2 Trial): outcome after 3 years of follow-up. Eur Heart J. 2008;29: 1259-1266.
66. Widimsky P, Bilkova D, Penicka M, Novak M, Lanikova M, Porizka V, Groch L, Zelizko M, Budesinsky T, Aschermann M, for the PRAGUE Study Group Investigators. Long-term outcomes of patients with acute myocardial infarction presenting to hospitals without catheterization laboratory and randomized to immediate thrombolysis or interhospital transport for primary percutaneous coronary intervention: five years' follow-up of the PRAGUE-2 Trial. Eur Heart J. 2007;28:679-684.
67. Henriques JP, Zijlstra F, van't Hof AW, de Boer MJ, Dambrink JH, Gosselink AT, Hoorntje JC, Ottervanger JP, Suryapranata H. Primary percutaneous coronary intervention vs thrombolytic treatment: long-term follow up according to infarct location. Heart. 2006;92:75-79.
68. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. BMJ. 1997;315:629-634.